Autor: "Quezada SA" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
Autorzy:: Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumor IRCCS 'Fondazione G. Pascale', Naples, Italy. .
Agarwala SS; Hematology & Oncology, Temple University and Cancer Expert Now, Bethlehem, PA, USA.
Blank C; Netherlands Cancer Institute, Amsterdam, Netherlands.
Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori 'Fondazione Pascale' IRCCS, Naples, Italy.
Carvajal RD; Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Ernstoff MS; Developmental Therapeutics Program, Division of Cancer Therapy & Diagnosis, NCI, Bethesda, NIHMD, USA.
Ferrone S; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Fox BA; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Cancer Institute, Portland, OR, USA.
Gajewski TF; Department of Pathology and Department of Medicine (Section of Hematology/Oncology), University of Chicago, Chicago, IL, USA.
Garbe C; Center for Dermato-Oncology, University-Department of Dermatology, Tuebingen, Germany.
Grob JJ; Dermatology Department, Hopital de La Timone, Aix-Marseille, Marseille, France.
Hamid O; Medical Oncology, The Angeles Clinic and Research Institute, a Cedar-Sinai Affiliate, Los Angeles, CA, USA.
Krogsgaard M; New York Grossman School of Medicine, New York University Langone, New York, NY, USA.
Lo RS; Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Lund AW; Ronald O. Perelman Department of Dermatology, Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA.
Madonna G; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy.
Michielin O; Precision Oncology Center and Melanoma Clinic, Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Neyns B; Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Osman I; New York University Langone Medical Center, New York, NY, USA.
Peters S; UNIL, Medical Oncology Department European Thoracic Oncology Platform (ETOP), Specialized Thoracic Tumor Consultation, Oncology Department UNIL CHUV Thoracic Tumor Center, Lausanne University ESMO President, Scientific Coordinator, Lausanne, Switzerland.
Poulikakos PI; Department of Oncological Sciences, Department of Dermatology Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA.
Quezada SA; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London, UK.
Reinfeld B; Department of Medicine, Department of Medicine, Division of Hematology/Oncology Vanderbilt University Medical Center (VUMC), Graduate Program in Cancer Biology, Vanderbilt University, Nashville, TN, USA.
Zitvogel L; Tumour Immunology and Immunotherapy of Cancer, European Academy of Tumor Immunology, Gustave Roussy, University Paris Saclay, INSERM, Villejuif Grand-Paris, France.
Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Thurin M; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, Rockville, NIHMD, USA.; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2022 Sep 04; Vol. 20 (1), pp. 391. Date of Electronic Publication: 2022 Sep 04.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*
Melanoma*/genetics
Biomarkers ; Humans ; Immunotherapy/methods ; Italy ; Pandemics ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy).
Autorzy:: Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Instituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy. .
Blank C; Netherlands Cancer Institute, Amsterdam, The Netherlands.
Dummer R; Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland.
Ernstoff MS; Developmental Therapeutics Program, Division of Cancer Therapy & Diagnosis, NCI, NIH, Bethesda, MD, USA.
Ferrone S; Department of Surgery Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Fox BA; Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, OR, USA.
Gajewski TF; Department of Pathology and Department of Medicine (Section of Hematology/Oncology), University of Chicago, Chicago, IL, USA.
Garbe C; Center for Dermato-Oncology, University-Department of Dermatology, Tuebingen, Germany.
Hwu P; Moffitt Cancer Center, Tampa, FL, USA.
Kalinski P; Cancer Vaccine and Dendritic Cell Therapies, Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, NY, USA.
Krogsgaard M; Medical School, New York University Langone, New York, NY, USA.
Lo RS; Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Luke JJ; Cancer Immunotherapeutic Center of UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Neyns B; Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Postow MA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Quezada SA; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London, UK.
Teng MWL; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Trinchieri G; Laboratory of Integrative Cancer Immunology (LICI), Center for Cancer Research, NCI, NIH, Bethesda, MD, USA.
Testori A; Image Rigenerative Clinic-Skin Oncology Division, Milan, Italy.; Chairman Surgical Subgroup EORTC Melanoma Group Brussels, Brussels, Belgium.
Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori 'Fondazione Pascale' IRCCS, Naples, Italy.
Osman I; New York University Langone Medical Center, New York, NY, USA.
Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Thurin M; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA.; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2021 Jun 30; Vol. 19 (1), pp. 278. Date of Electronic Publication: 2021 Jun 30.
Typ publikacji:: Congress
MeSH Terms:: Immunotherapy*
Melanoma*/drug therapy
Humans ; Italy ; Molecular Targeted Therapy ; Tumor Microenvironment

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Quezada SA"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Język